Meilleure Health International Industry Group Management
Management criteria checks 4/4
Meilleure Health International Industry Group's CEO is Wen Chuan Zhou, appointed in Sep 2013, has a tenure of 11.25 years. total yearly compensation is HK$661.00K, comprised of 181.5% salary and -81.5% bonuses, including company stock and options. directly owns 0.78% of the company’s shares, worth HK$9.26M. The average tenure of the management team and the board of directors is 8.4 years and 9.2 years respectively.
Key information
Wen Chuan Zhou
Chief executive officer
HK$661.0k
Total compensation
| CEO salary percentage | 181.5% |
| CEO tenure | 11.3yrs |
| CEO ownership | 0.8% |
| Management average tenure | 8.4yrs |
| Board average tenure | 9.2yrs |
Recent management updates
Recent updates
Meilleure Health International Industry Group's (HKG:2327) Shareholders May Want To Dig Deeper Than Statutory Profit
Oct 04
Earnings Not Telling The Story For Meilleure Health International Industry Group Limited (HKG:2327) After Shares Rise 34%
Sep 05Meilleure Health International Industry Group (HKG:2327) Has A Somewhat Strained Balance Sheet
Aug 30Meilleure Health International Industry Group Limited's (HKG:2327) 31% Share Price Plunge Could Signal Some Risk
Jul 19Meilleure Health International Industry Group (HKG:2327) Will Be Hoping To Turn Its Returns On Capital Around
Jun 17Optimistic Investors Push Meilleure Health International Industry Group Limited (HKG:2327) Shares Up 32% But Growth Is Lacking
May 03Meilleure Health International Industry Group's (HKG:2327) Earnings Are Of Questionable Quality
Apr 04Some Confidence Is Lacking In Meilleure Health International Industry Group Limited (HKG:2327) As Shares Slide 30%
Feb 28Returns Are Gaining Momentum At Meilleure Health International Industry Group (HKG:2327)
Jan 23Returns At Meilleure Health International Industry Group (HKG:2327) Appear To Be Weighed Down
Aug 17Investors Met With Slowing Returns on Capital At Meilleure Health International Industry Group (HKG:2327)
Oct 18Is Meilleure Health International Industry Group (HKG:2327) A Risky Investment?
Sep 06Investors Will Want Meilleure Health International Industry Group's (HKG:2327) Growth In ROCE To Persist
Jul 12Does Meilleure Health International Industry Group (HKG:2327) Have A Healthy Balance Sheet?
Sep 09Meilleure Health International Industry Group (HKG:2327) Shareholders Will Want The ROCE Trajectory To Continue
May 15Meilleure Health International Industry Group (HKG:2327) Seems To Use Debt Rather Sparingly
Apr 18Did You Miss Meilleure Health International Industry Group's (HKG:2327) Impressive 124% Share Price Gain?
Jan 29
Here's What We Think About Meilleure Health International Industry Group's (HKG:2327) CEO Pay
Dec 08CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | HK$31m |
| Mar 31 2024 | n/a | n/a | HK$36m |
| Dec 31 2023 | HK$661k | HK$1m | HK$41m |
| Sep 30 2023 | n/a | n/a | HK$33m |
| Jun 30 2023 | n/a | n/a | HK$25m |
| Mar 31 2023 | n/a | n/a | HK$22m |
| Dec 31 2022 | HK$987k | HK$1m | HK$18m |
| Sep 30 2022 | n/a | n/a | HK$23m |
| Jun 30 2022 | n/a | n/a | HK$28m |
| Mar 31 2022 | n/a | n/a | HK$44m |
| Dec 31 2021 | HK$2m | HK$1m | HK$60m |
| Sep 30 2021 | n/a | n/a | HK$72m |
| Jun 30 2021 | n/a | n/a | HK$84m |
| Mar 31 2021 | n/a | n/a | HK$84m |
| Dec 31 2020 | HK$2m | HK$1m | HK$83m |
| Sep 30 2020 | n/a | n/a | HK$32m |
| Jun 30 2020 | n/a | n/a | -HK$19m |
| Mar 31 2020 | n/a | n/a | -HK$19m |
| Dec 31 2019 | HK$800k | HK$800k | -HK$20m |
| Sep 30 2019 | n/a | n/a | HK$31m |
| Jun 30 2019 | n/a | n/a | HK$83m |
| Mar 31 2019 | n/a | n/a | HK$82m |
| Dec 31 2018 | HK$540k | HK$540k | HK$81m |
| Sep 30 2018 | n/a | n/a | HK$81m |
| Jun 30 2018 | n/a | n/a | HK$81m |
| Mar 31 2018 | n/a | n/a | HK$81m |
| Dec 31 2017 | HK$540k | HK$540k | HK$80m |
Compensation vs Market: Wen Chuan's total compensation ($USD85.01K) is below average for companies of similar size in the Hong Kong market ($USD348.00K).
Compensation vs Earnings: Wen Chuan's compensation has been consistent with company performance over the past year.
CEO
Wen Chuan Zhou (41 yo)
11.3yrs
Tenure
HK$661,000
Compensation
Ms. Wen Chuan Zhou has been the Chief Executive Officer and Executive Director of Meilleure Health International Industry Group Limited (formerly known as U-Home Group Holdings Limited) since September 23,...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Co-Chairman of the Board | 11.3yrs | HK$800.00k | 34.46% HK$ 408.9m | |
| Executive Co-Chairman of the Board | 7.2yrs | no data | 1.83% HK$ 21.7m | |
| Vice Chairman & CEO | 11.3yrs | HK$661.00k | 0.78% HK$ 9.3m | |
| CFO & Company Secretary | 5.4yrs | no data | no data | |
| Human Resources Manager | no data | no data | no data |
8.4yrs
Average Tenure
61yo
Average Age
Experienced Management: 2327's management team is seasoned and experienced (8.4 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Co-Chairman of the Board | 11.3yrs | HK$800.00k | 34.46% HK$ 408.9m | |
| Executive Co-Chairman of the Board | 7.2yrs | no data | 1.83% HK$ 21.7m | |
| Vice Chairman & CEO | 11.3yrs | HK$661.00k | 0.78% HK$ 9.3m | |
| Independent Non-Executive Director | 11.3yrs | HK$180.00k | no data | |
| Non-Executive Director | 9.2yrs | HK$180.00k | no data | |
| Independent Non-Executive Director | less than a year | no data | no data | |
| Independent Non-Executive Director | 5.6yrs | HK$120.00k | no data |
9.2yrs
Average Tenure
61yo
Average Age
Experienced Board: 2327's board of directors are considered experienced (9.2 years average tenure).
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/22 08:15 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/06/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Meilleure Health International Industry Group Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Li Wu | Tianfeng Securities Brokerage Co., Ltd |